Quynh‐Thu Le

Active 1997–2026

Also published as
Quynh-Thu Le · Quynh Thu Le
196
Papers
36,396
Citations
99
h-index
183
i10-index

Citations

Citations per year for Quynh‐Thu Le1958: 1 citations1995: 1 citations1998: 1 citations1999: 1 citations2000: 9 citations2001: 17 citations2002: 41 citations2003: 76 citations2004: 79 citations2005: 94 citations2006: 135 citations2007: 196 citations2008: 214 citations2009: 239 citations2010: 301 citations2011: 334 citations2012: 353 citations2013: 329 citations2014: 314 citations2015: 303 citations2016: 277 citations2017: 288 citations2018: 245 citations2019: 1,053 citations2020: 1,361 citations2021: 1,342 citations2022: 1,054 citations2023: 757 citations2024: 1,340 citations2025: 634 citations2026: 28 citations1959–1994: no citations, so these years are not shown1996–1997: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,830 citing papers, 26.6% of this breakdownChina: 2,474 citing papers, 17.2% of this breakdownUnited Kingdom: 735 citing papers, 5.1% of this breakdownGermany: 647 citing papers, 4.5% of this breakdownItaly: 562 citing papers, 3.9% of this breakdownCanada: 528 citing papers, 3.7% of this breakdownFrance: 459 citing papers, 3.2% of this breakdownNetherlands: 430 citing papers, 3% of this breakdownJapan: 384 citing papers, 2.7% of this breakdownAustralia: 368 citing papers, 2.6% of this breakdownSwitzerland: 291 citing papers, 2% of this breakdownSpain: 278 citing papers, 1.9% of this breakdown
0%26.6%Other 23.6%

Fields

  • Medicine54.9%
  • Biochemistry, Genetics and Molecular Biology29.6%
  • Physics and Astronomy4.3%
  • Immunology and Microbiology4.1%
  • Engineering1.7%
  • Computer Science1.5%
  • Other3.9%

Topics

  • Head and Neck Cancer Studies8.4%
  • Cancer, Hypoxia, and Metabolism3.8%
  • Advanced Radiotherapy Techniques3%
  • Cancer Immunotherapy and Biomarkers2.5%
  • Esophageal Cancer Research and Treatment1.9%
  • Cancer-related molecular mechanisms research1.9%
  • Other78.5%

Coauthors

All papers

Open in search
  1. Nasopharyngeal carcinoma

    Authors: , , , , , - The Lancet 2019 cited by 3,065

  2. Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2018 cited by 1,295

  3. The changing therapeutic landscape of head and neck cancer

    Authors: , , , - Nature Reviews Clinical Oncology 2019 cited by 812

  4. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)

    Authors: , , , , , , , , , , , , , , , , , , - Journal for ImmunoTherapy of Cancer 2019 cited by 738

  5. Hypoxia-Induced Lysyl Oxidase Is a Critical Mediator of Bone Marrow Cell Recruitment to Form the Premetastatic Niche

    Authors: , , , , , , , - Cancer Cell 2009 cited by 1,216

  6. Adaptive Region-Specific Loss for Improved Medical Image Segmentation

    Authors: , , , , , , , , , , , , , , - IEEE Transactions on Pattern Analysis and Machine Intelligence, IEEE Trans. Pattern Anal. Mach. Intell. 2023 cited by 59

  7. Delineation of the neck node levels for head and neck tumors: A 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines

    Authors: , , , , , , , , , , , , - Radiotherapy and Oncology 2013 cited by 850

  8. Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose

    Authors: , , , , , , , , , , , , , , , - New England Journal of Medicine 2008 cited by 1,483

  9. Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2021 cited by 391

  10. Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002)

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2021 cited by 374

  11. Pancreatic tumors show high levels of hypoxia

    Authors: , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2000 cited by 647

  12. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Zoltán Takácsi Nagy, Ju‐Whei Lee, Catherine Fortpied, Jonathan Harris, Jean Bourhis, Anne Aupérin, Pierre Blanchard, Jean‐Pierre Pignon, David J. Adelstein, M. Alfonsi, Y. Belkacemi, Voichita Bar‐Ad, J. Bernier, Åse Bratland, G. Calais, Brittany Campbell, Jimmy J. Caudell, Sylvie Chabaud, Emmanuel Chamorey, Devendra Chaukar, Kwang Nam Choi, Olivier Choussy, Laurence Collette, Judith Cruz, Carla Dani, Etienne Dauzier, Arlene A. Forastiere, P. Garaud, V. Grégoire, A. Hackshaw, E. Haddad, Bruce G. Haffty, Aaron R. Hansen, Stefanie Hayoz, Jean-Claude Horiot, Branislav Jeremić, Theodore Karrison, Johannes A. Langendijk, M. Lapeyre, Éric Lartigau, Traci Leong, Quynh‐Thu Le, Patricia Lee, Freddi Lewin, Aihua Lin, Alberto Lopes, Samir Mehta, James Moon, Elizabeth Moyal, Bob‐Valéry Occéan, P. Olmi, Roberto Orecchia, Brian O’Sullivan, Jens Overgaard, Claire Petit, Harvey Quon, Giuseppe Sanguineti, Tuvana Satar, John Simes, Christian Simon, Clément Sire, S. Staar, C. Stromberger, P. Strojan, Stéphane Temam, David Thomson, A. Timochenko, Valter Torri, Vassilikì Tseroni, Jan B. Vermorken and 5 more - Radiotherapy and Oncology 2021 cited by 376

  13. Identification of cell types in multiplexed in situ images by combining protein expression and spatial information using CELESTA

    Authors: , , , , , , , , , , , , , , , , - Nature Methods 2022 cited by 120

  14. Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sue S. Yom, Frank Zimmermann, Cai Grau - Radiotherapy and Oncology 2017 cited by 405

  15. Galectin-1–driven T cell exclusion in the tumor endothelium promotes immunotherapy resistance

    Authors: , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2019 cited by 175

  16. International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Radiotherapy and Oncology 2017 cited by 376

  17. Human Papillomavirus and Overall Survival After Progression of Oropharyngeal Squamous Cell Carcinoma

    Authors: , , , , , , , , , , , , - Journal of Clinical Oncology 2014 cited by 546

  18. Hypoxia-Inducible mir-210 Regulates Normoxic Gene Expression Involved in Tumor Initiation

    Authors: , , , , , , , , - Molecular Cell 2009 cited by 628

  19. Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pierre Blanchard, Jean Bourhis, Benjamin Lacas, Jean‐Pierre Pignon, Jacques Bernier, Quynh‐Thu Le, Jens Overgaard, Masheh KB Parmar, Andy Trotti, Jai Prakash Agarwal, Anne Aupérin, Kian Ang, Hassan K. Awwad, Almalina Bacigalupo, Harry Bartelink, E Benhamou, Jacques Bernier, Pierre Blanchard, Jean Bourhis, Wilfried Budach, Imjai Chitapanarux, Kwan Ho Cho, Laurence Collette, Renzo Corvò, Carla Dani, Stanley Dische, W. Dobrowsky, James W. Denham, C.M.L. Driessen, C. Fallai, Beth M. Beadle, Sarbani Ghosh Laskar, Sushmita Ghoshal, Cai Grau, Vincent Grégoire, John Hay, Carla van Herpen, A Hliniak, Jørgen Johansen, Claus Andrup Kristiansen, Valentina Krstevska, Benjamin Lacas, Johannes A. Langendijk, M. Lapeyre, Quynh‐Thu Le, Mohamed Lotayef, B. Maciejewski, P. Maingon, Wojciech Michalski, Sung Ho Moon, Per Nilsson, Patrizia Olmi, Matthew Nankivell, Kinji Nishiyama, Brian O’Sullivan, Jens Overgaard, Mahesh Parmar, Jean‐Pierre Pignon, Michael Poulsen, Kunnambath Ramadas, Anupam Rishi, David I. Rosenthal, Giuseppe Sanguineti, Michele I. Saunders, Christian Sire, Krzysztof Składowski, Luís Souhami, Rafał Suwiński, Z. Szutkowski, Nitin Tandon and 12 more - The Lancet Oncology 2017 cited by 339

  20. Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity‐modulated radiotherapy

    Authors: , , , , , , , , , , , , , , , , , , - Cancer 2015 cited by 362

  21. Understanding High-Dose, Ultra-High Dose Rate, and Spatially Fractionated Radiation Therapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marie‐Catherine Vozenin, May Abdel–Wahab, James S. Welsh, Xiaodong Wu, Charles L. Limoli - International Journal of Radiation Oncology*Biology*Physics 2020 cited by 126

  22. NFE2L2 Mutations Enhance Radioresistance in Head and Neck Cancer by Modulating Intratumoral Myeloid Cells

    Authors: , , , , , , , , , , , , , , , , , , , - Cancer Research 2023 cited by 57

  23. Randomized Phase III Trial to Test Accelerated Versus Standard Fractionation in Combination With Concurrent Cisplatin for Head and Neck Carcinomas in the Radiation Therapy Oncology Group 0129 Trial: Long-Term Report of Efficacy and Toxicity

    Authors: , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2014 cited by 474

  24. Papaverine and its derivatives radiosensitize solid tumors by inhibiting mitochondrial metabolism

    Authors: , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2018 cited by 171